Randomized Control Trial of Micronized Purified Flavonoid Fraction for Post Operative Treatment i… (NCT06184438) | Clinical Trial Compass
CompletedPhase 4
Randomized Control Trial of Micronized Purified Flavonoid Fraction for Post Operative Treatment in Anal Fistula Surgery
Taiwan106 participantsStarted 2023-12-13
Plain-language summary
The aim of this study is to evaluate the effect of micronized purified flavonoid fraction on postoperative symptoms after surgery of anorectal fistulas.
Who can participate
Age range20 Years – 85 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients who undergo fistulectomy or fistulotomy are included.
Exclusion Criteria:
* Emergency operation
* Participants who had Trans-sphincteric anal fistula, Extra-sphincteric anal fistula
* Participants accompanied by severe liver cirrhosis
* Participants accompanied by coagulation disorders
* Participants taking anticoagulant
* Participants taking corticosteroids as long-term medication.
* Participants who had colorectal cancer
* Participants taking analgesic drugs (morphine or others) as long-term medication
* Participants bed-ridden
* Participants who had history of human immunodeficiency virus (HIV) infection
* Pregnant woman
What they're measuring
1
Post-operative pain
Timeframe: 0-7 days
2
Frequency of dressing replacement
Timeframe: 0-7 days
Trial details
NCT IDNCT06184438
SponsorTaipei Medical University Shuang Ho Hospital